Medications

Novel agent promising for the treatment of schizophrenia

(HealthDay)—For patients with an acute exacerbation of schizophrenia, SEP-363856, a non-D2-receptor-binding drug that has agonist activity at trace amine-associated receptor 1 (TAAR1) and 5-hydroxytryptamine type 1A receptors, ...

Medical research

Battery-free pacemaker reduces equipment to size of a dime

Researchers have developed and tested for the first time in vivo a miniaturized, battery-free pacemaker that supports optical and electrical multisite stimulation. The new device is powered wirelessly, omitting the weight ...

page 11 from 40